Article
When Guidelines Meet Reality: The Combined Impact of Assay Variability and Prescribing Differences on TSH Management in Thyroid Cancer
2025-11-04
Abstract excerpt
<h4>Background: </h4> /Objectives: Patients with differentiated thyroid cancer (DTC) receive thyroxine substitution targeting thyroid-stimulating hormone (TSH) levels adapted to their response-to-treatment category. However, variations in prescription and TSH inter-assay variability may result in over- or undertreatment. <h4>Methods:</h4> We measured TSH in 220 consecutive DTC patients using three automated immuno...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6d43038a-9732-5799-be9d-9bdaf7b3f281
- DOI
- 10.20944/preprints202511.0174.v1
